Today: 29 April 2026
Super Micro (SMCI) stock closes lower — what investors watch before Feb. 3 earnings

Super Micro (SMCI) stock closes lower — what investors watch before Feb. 3 earnings

New York, January 26, 2026, 16:01 (EST) — After-hours trading

Shares of Super Micro Computer (SMCI.O) dropped 2.8% on Monday, closing at $30.80 after fluctuating between $31.51 and $30.66 during the session. The stock held steady in after-hours trading. Trading volume hit roughly 18.8 million shares.

The drop comes just a week ahead of new data. Super Micro plans to release its fiscal second-quarter results on Feb. 3, followed by a conference call at 5 p.m. ET.

U.S. stocks closed up, but SMCI bucked the trend. The Nasdaq-tracking Invesco QQQ climbed around 0.6%, while the SPDR S&P 500 ETF added about 0.7%.

Data center hardware stocks showed a mixed picture. Dell Technologies edged up roughly 0.5%, Hewlett Packard Enterprise rose 1.4%, but Nvidia fell around 0.6%.

Super Micro’s profits have been tossed around by the timing of large AI server orders. In October, the company slashed its first-quarter revenue forecast to $5 billion after clients delayed deliveries. Despite that, it stuck to its full-year revenue target of at least $33 billion and highlighted over $12 billion in new business expected in the second quarter.

In its November first-quarter report, the company fell short of Wall Street expectations and blamed shipment timing once again. It projected second-quarter revenue between $10 billion and $11 billion, well above the average analyst estimate of $7.83 billion, according to LSEG data cited by Reuters.

But the downside risks remain. Super Micro has flagged issues with internal controls over financial reporting — the safeguards designed to ensure accurate accounts — a concern that has weighed on the stock at times.

The sector outlook is uneven. Morgan Stanley downgraded its stance on the North American IT hardware group this month, pointing to softer enterprise demand and increasing component costs.

For traders, Feb. 3 isn’t just about sales figures. They’re focused on whether gross margin — the slice of revenue remaining after production costs — can hold steady, and if management will offer clearer guidance on the timing of big order shipments.

Investors are eyeing the earnings report and call scheduled for Feb. 3, right after the U.S. market closes.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play
Previous Story

Marvell stock climbs in New York trade as Fed week puts AI-linked chip names in play

Oracle stock jumps nearly 3% as TikTok U.S. tie-up comes back into focus
Next Story

Oracle stock jumps nearly 3% as TikTok U.S. tie-up comes back into focus

Go toTop